Skip to main content

Baltimore City-Based Medical Device Startup ReGelTec raises $3.75M in Series A Funding

ReGelTec, a Baltimore City-based medical device startup, has raised $3.75M in Series A funding. The new funding will assist the company in conducting clinical trials in South America for its “HYDRAFIL” hydrogel, a treatment for chronic lower back pain. According to, ReGelTec is overseeing trials remotely via Zoom and 11 patients have undergone the procedure thus far.

Read More